IndraLab

Statements


Ubiquitin-proteasome inhibits USP13. 4 / 4
| 4

reach
"Bortezomib treatment increased accumulation of USP13 (Fig. 4E), indicating that USP13 degradation is mediated by the ubiquitin-proteasome system."

reach
"Here, we report that USP13 degradation is mediated by the ubiquitin-proteasome system."

reach
"However, despite the requirement of IL-1R8 of IL-37 to exert its function, upon IL-37 treatment IL-1R8 is degraded by the ubiquitin-proteasome system, a pathway that is negatively regulated by the deu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Inhibition of proteasome, but not lysosome or immunoproteasome, attenuates LPS-induced USP13 degradation, suggesting USP13 degradation is mediated by the ubiquitin-proteasome system."